Hurley, S. F., Matthews, J. P., & Guymer, R. H. (2008). Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration. BioMed Central.
Citação norma ChicagoHurley, Susan F., Jane P. Matthews, and Robyn H. Guymer. Cost-effectiveness of Ranibizumab for Neovascular Age-related Macular Degeneration. BioMed Central, 2008.
MLA citiranjeHurley, Susan F., Jane P. Matthews, and Robyn H. Guymer. Cost-effectiveness of Ranibizumab for Neovascular Age-related Macular Degeneration. BioMed Central, 2008.
Opozorilo: Ti citati niso vedno 100% točni.